HYPOGLYCAEMIC SYNDROMES AND ANTIBODIES TO PANCREATIC ISLET CELLS.DI MARIO U; TAMBURRANO G; IAVICOLI M et al.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 29; NO 3; PP. 523-524; BIBL. 13 REF.Article

GLUCAGON AND GROWTH HORMONE SECRETION IN INSULIN-TREATED DIABETICS: EFFECTS OF ADDED SULFONYLUREAS.FALLUCCA F; IAVICOLI M; MENZINGER G et al.1978; METABOLISM; U.S.A.; DA. 1978; VOL. 27; NO 1; PP. 5-11; BIBL. 23 REF.Article

COMPARATIVE TRIALS WITH MONOCOMPONENT (MC) AND MONOSPECIES (MS) PORK INSULINS IN THE TREATMENT OF DIABETES MELLITUS. INFLUENCE ON ANTIBODY LEVELS, ON INSULIN REQUIREMENT AND ON SOME COMPLICATIONS = ESSAIS COMPARES AVEC LES INSULINES DE PORC MONOCOMPOSE (MC) ET MONOSPECIFIQUE (MS) DANS LE TRAITEMENT DU DIABETE SUCRE. INFLUENCE SUR LES TAUX DES ANTICORPS, SUR LE BESOIN EN INSULINE ET SUR QUELQUES COMPLICATIONSANDREANI D; IAVICOLI M; TAMBURRANO G et al.1974; HORMONE METABOL. RES.; GERM.; DA. 1974; VOL. 6; NO 6; PP. 447-454; BIBL. 26 REF.Article

CIRCULATING IMMUNE COMPLEXES IN DIABETICS WITH SEVERE MICROANGIOPATHY: EVALUATION BY TWO DIFFERENT METHODANDREANI D; DI MARIO U; GALFO C et al.1982; ACTA ENDOCRINOL. (KBH.); ISSN 0001-5598; DNK; DA. 1982; VOL. 99; NO 2; PP. 239-244; BIBL. 28 REF.Article

Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulinPARILLO, M; MURA, A; IOVINE, C et al.Diabetes care. 1992, Vol 15, Num 2, pp 173-177, issn 0149-5992Article

Cardiac performance and mass in adults with hypopituitarism : effects of one year of growth hormone treatmentVALCAVI, R; GADDI, O; ZINI, M et al.The Journal of clinical endocrinology and metabolism. 1995, Vol 80, Num 2, pp 659-666, issn 0021-972XArticle

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agentsDEL PRATO, S; VIGILI DE KREUTZENBERG, S; RICCIO, A et al.Diabetologia (Berlin). 1990, Vol 33, Num 11, pp 688-695, issn 0012-186XArticle

Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agentsIAVICOLI, M; CUCINOTTA, D; DE MATTIA, G et al.Diabetic medicine. 1988, Vol 5, Num 9, pp 849-855, issn 0742-3071Article